Back to results
US 12,268,694 B2Granted
Combination pharmaceutical agents as RSV inhibitors
AssigneeEnanta Pharmaceuticals, Inc.
InventorsBrian C. Shook, In Jong Kim, Thomas P. Blaisdell, Jianming Yu, Joseph Panarese, Kai Lin, Michael H. J. Rhodin, Nicole V. McAllister, Yat Sun Or
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition useful for treating a Respiratory Syncytial Virus (RSV) infection, comprising a compound which is or a pharmaceutically acceptable salt thereof, and a second anti-respiratory syncytial virus agent.
Claims4
A pharmaceutical composition comprising a compound which is
- or a pharmaceutically acceptable salt thereof,
- a second anti-respiratory syncytial virus agent;
- and
- a pharmaceutically acceptable carrier or excipient.
1 more element
Dependencies are inferred from the claim text.